Our News on Newswise

Genomic Differences May Be Key to Overcoming Prostate Cancer Disparities Among African American Men

In a new article published in Clinical Cancer Research, Moffitt Cancer Center researchers describes the immune-oncologic differences in prostate cancer tumors of African American men and how those variations may be exploited to develop more...
21-Oct-2020 9:55 AM EDT Add to Favorites

Moffitt Researchers Develop Tool to Better Predict Treatment Course for Lung Cancer Patients

In a new article published in Nature Communications, Moffitt Cancer Center researcher demonstrate how a deep learning model using positron emission tomography/computerized tomography radiomics can identify which non-small cell lung cancer patients...
16-Oct-2020 9:30 AM EDT Add to Favorites

Moffitt Researchers Discover Specific Molecules that Promote Cancer Progression

In a new article published in the journal Nature Communications, Moffitt Cancer Center researchers describe how the protein TAp63 controls levels of RNA molecules, which subsequently connects the activities of p53 and AKT to promote disease...
15-Oct-2020 9:40 AM EDT Add to Favorites

Moffitt Researchers Identify Driver of Further Metastasis in BRAF Inhibitor Resistant Melanoma

In a new article published in the Journal of Investigative Dermatology, Moffitt researchers identify erythropoietin-producing hepatocellular receptor A2 (EphA2) as a driver of metastasis and BRAF-MEK inhibitor resistance in melanoma.
2-Sep-2020 10:45 AM EDT Add to Favorites

Acidic Niche Keeps Lymphatic System in Check during Immune Response, Moffitt Researchers Say

In a new article published in Nature Communications, Moffitt Cancer Center researchers describe a novel acidic niche within lymph nodes that plays an integral role in regulating T cell activation.
18-Aug-2020 9:10 AM EDT Add to Favorites

Moffitt Researchers Identify Factors to Predict Severe Toxicities in CAR T Patients

In a new study published in Clinical Cancer Research, Moffitt Cancer Center researchers identify possible factors that could help physicians know if patients are at higher risk for severe adverse events before they receive CAR T therapy.
15-Jul-2020 10:40 AM EDT Add to Favorites

Moffitt Researchers Find Dual Inhibitor May Be Safer for Chronic Lymphocytic Leukemia Patients

Moffitt Cancer Center researchers want to learn more about how PI3K inhibitor therapy works with the body’s immune system to determine if there are ways to predict or mitigate associated adverse effects. Their findings were published in the July...
14-Jul-2020 9:00 AM EDT Add to Favorites

Moffitt Researchers Identify Protein that Causes Epithelial Cancers to Spread

In a new article published in the July issue of Cancer Research, Elsa Flores, Ph.D., and her team discovered a key protein that oscillates its expression through microRNA regulation to facilitate cancer spread to distant organs. This protein is...
6-Jul-2020 9:00 AM EDT Add to Favorites


See All News

Our Experts on Newswise

CANCER AND COVID-19: Moffitt Cancer Center Experts & Resources

1-Apr-2020 8:40 AM EDT

Newswise: AnnaGiuliano_Euroginopeningtalk_2017.jpg

Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference

Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT

See All Experts

Our YouTube Videos

About

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is the No. 11 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,000 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.

Contacts

Kim Polacek
Senior Public Relations Account Coordinator

Kim.Polacek@Moffitt.org

813-745-7408

Steven Blanchard
Public Relations Account Coordinator

Steven.Blanchard@Moffitt.org

813-745-1718

Sara Bondell
Public Relations Account Coodinator

Sara.Bondell@moffitt.org

813-745-1353

Patty Kim
Public Relations Manager

Patty.Kim@Moffitt.org

813-745-7322

Twitter

close
0.57823